In this article, we present a case of a patient with relapsed Hodgkin lymphoma who responded to salvage chemotherapy incorporating brentuximab vedotin, a novel agent.
GSK plc announced positive data from the ZOSTER-049 long-term follow-up phase III trial which followed participants for up to approximately 11 years following initial vaccination with Shingrix (Recombinant Zoster Vaccine or RZV)
Concise infographic summaries on early breast cancer stratification
On 24 April each year, the Confederation of Meningitis Organisations (CoMO) lead a dedicated campaign to promote awareness of Meningitis.